Nisterime acetate

Nisterime acetate
Clinical data
Routes of
Synonyms 2α-Chloro-5α-androstan-17β-ol-3-one O-(p-nitrophenyl)oxime 17β-acetate; 2α-Chloro-4,5α-dihydrotestosterone O-(p-nitrophenyl)oxime 17β-acetate; 2α-Chloro-3-(p-nitrophenoxy)imino-5α-androstan-17β-ol 17β-acetate
CAS Number 51354-31-5
PubChem (CID) 10006270
ChemSpider 16741388
KEGG D05174
Chemical and physical data
Formula C27H35ClN2O5
Molar mass 503.036 g/mol
3D model (Jmol) Interactive image

Nisterime acetate (USAN) (developmental code name ORF-9326), also known as 2α-chloro-4,5α-dihydrotestosterone O-(p-nitrophenyl)oxime 17β-acetate or as 2α-chloro-5α-androstan-17β-ol-3-one O-(p-nitrophenyl)oxime 17β-acetate, is a synthetic, orally active anabolic-androgenic steroid (AAS) and a derivative of dihydrotestosterone (DHT) that was developed as a postcoital contraceptive but was never marketed.[2][3][1] It is an androgen ester – specifically, the C17α acetate ester of nisterime.[2] Unlike antiprogestogens like mifepristone, nisterime acetate does not prevent implantation and instead induces embryo resorption as well as interrupts the post-implantation stage of pregnancy.[4]

Nisterime acetate is described as an androgen by some sources.[2][5] However, it has also been reported that the drug lacks hormonal activity in bioassays, including androgenic, estrogenic, or progestogenic activity (as well as antagonistic activity).[1][6] This finding has been described as puzzling in light of the potent abortifacient activity of the drug in animals and it has been said that its mechanism of action remains unknown.[6]

See also


  1. 1 2 3 DW, Hahn, GO, Allen, & FC, Greenslade (1977, March). The post-implantive contragestational activity of 17 beta-acetoxy-2 alpha chloro-3-(p-nitrophenoxy) imino-5-androstane (ORF 9326) in the rat. In Federation Proceedings (Vol. 36, No. 3, p. 342).
  2. 1 2 3 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 876–. ISBN 978-1-4757-2085-3.
  3. Patrick JE, Weintraub HS, McGuire JL (1978). "Disposition of ORF 9326, a novel contragestational steroid, in animals". Steroids. 32 (2): 147–56. PMID 102053.
  4. Stanley R. Glasser; David W. Bullock (6 December 2012). Cellular and Molecular Aspects of Implantation. Springer Science & Business Media. pp. 479–. ISBN 978-1-4613-3180-3.
  6. 1 2 Gerald I. Zatuchni; Miriam H. Labbok; John J. Sciarra; Northwestern University (Evanston, Ill.). Program for Applied Research on Fertility Regulation (1980). Research frontiers in fertility regulation. Harper & Row. ISBN 978-0-06-142902-6. ORF 9326 (17 B-acetoxy-2-a-chloro-3-(p-nitrophenoxy)imino-5a-androstane) is a derivative of dihydrotestosterone (Fig. 33-1). This compound was found to interrupt pregnancy in a number of species, but the fact that it has no hormonal activity is puzzling and its mechanism of action is still unknown. Cite uses deprecated parameter |coauthors= (help)

This article is issued from Wikipedia - version of the 12/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.